Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Retrovir (Zidovudine) Tablets
Company:  GlaxoSmithKline
Application No.:  020518s004, 019910s021 & 019655s032
Approval Date: 3/30/2001


Date created: April 19, 2005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.